Original Papers

  • Kurosawa M, Shimizu Y, Sutoh Y, Sutoh E: Un-sustained response to benralizumab in eosinophilic asthma with previous 3-year mepolizumab administration. J. Investig. Allergol. Clin. Immunol. 31(4):2021. (doi:10.18176/jiaci.0652)
  • Shimizu Y, Kurosawa M, Sutoh Y, Sutoh E: Long-term anti-interleukin 5 antibodies treatment in a patient with chronic eosinophilic pneumonia. J. Investig. Allergol. Clin. Immunol. 30: – ,2020. (doi:10.18176/jiaci.0468)
  • Kurosawa M, Sutoh Y, Sutoh E: Familial clustering of hypereosinophilic diseases treated with mepolizumab: a case report from Japan. Eur. Ann. Allergy Clin. Immunol.52:39-44,2020. (doi:10.23822/EurAnnACI.1764-1489.112)
  • Kurosawa M, Ogawa K, Sutoh E: Favorable clinical efficacy of mepolizumab on the upper and lower airways in severe eosinophilic asthma: a 48-week pilot study. Eur. Ann. Allergy Clin. Immunol. 51:213-221,2019. (doi:10.23822/EurAnnACI.1764-1489.94)
  • Kurosawa M, Sutoh E: Severe uncontrolled eosinophilic asthma, which responded to benralizumab after failure to respond to mepolizumab. Ann. Allergy Asthma Immunol. 122:431-433,2019. (doi:10.1016/j.anai.2018.12.04)
  • Kurosawa M, Sutoh E: Prospective open-label study of 48-week subcutaneous administration of mepolizumab in Japanese patients with severe eosinophilic asthma. J. Investig. Allergol. Clin. Immunol. 29:40-45,2019. (doi:10.18176/jiaci.0285)
  • Kurosawa M, Sutoh E, Sutoh Y: Interleukin (IL)-13, IL-17A, and mast cell chymase gene polymorphisms in bronchial asthma and chronic obstructive pulmonary disease – a pilot study in a Japanese population. J. Allergy Ther. 6:224,2015. (doi:10.4172/2155-6121.1000224)
  • Kurosawa M, Sutoh Y, Yukawa T, Hozawa S, Sutoh E: Solute carrier family 6 member 12 gene polymorphisms in Japanese patients with aspirin-exacerbated respiratory disease.J. Allergy Ther. 6:220,2015. (doi:10.4172/2155-6121.1000220)
  • Kurosawa M, Yukawa T, Hozawa S, Sutoh E: Single nucleotide polymorphisms in thymic stromal lymphopoietin gene are not associated with aspirin-exacerbated respiratory disease susceptibility- a pilot study in a Japanese population. J. Allergy Ther. 6:214,2015. (doi:10.4172/2155-6121.1000214)
  • Kurosawa M, Yukawa T, Sutoh E: A pilot study on effect of beta2-adrenergic receptor gene polymorphism on response to fluticasone/formoterol inhaler in patients with persistent asthma. J. Allergy Ther. 6:208,2015. (doi:10.4172/2155-6121.1000208)
  • Katelaris CH, Kurosawa M, Moon HB, Borres M, Johansson SGO: Pholcodine consumption and immunoglobulin E-sensitization in atopics from Australia, Korea, and Japan. Asia Pac. Allergy 4:86-90,2014.
  • Kikuchi K, Abe S, Kodaira K, Yukawa T, Hozawa S, Mochizuki H, Kurosawa M: Heat shock protein 70 gene polymorphisms in Japanese patients with aspirin-exacerbated respiratory disease. J. Investig. Med. 61:708-714,2013.
  • Kohyama K, Hashimoto M, Abe S, Kodaira K, Yukawa T, Hozawa S, Morioka J, Inamura H, Yano M, Ota M, Sagara H, Kurosawa M: Thromboxane A2 receptor +795T>C and chemoattractant recptor molecule expressed on Th2 cells -466T>C gene polymorphisms in Japanese patients with aspirin-exacerbated respiratory disease. Mol. Med. Rep. 5:477-482,2012.
  • Kohyama K, Abe S, Kodaira K, Yukawa T, Hozawa S, Sagara H, Kurosawa M: IL-13 and IL-17A gene polymorphisms in Japanese patients with aspirin-exacerbated respiratory disease. Ann. Allergy Asthma Immunol. 107:510-516,2011.
  • Kohyama K, Abe S, Kodaira K, Yukawa T, Hozawa S, Morioka J, Inamura H, Ota M, Sagara H, Kurosawa M: Polymorphisms of the CYP2C19 gene in Japanese patients with aspirin-exacerbated respiratory disease. J. Allergy Clin. Immunol. 128:1117-1120,2011.
  • Kohyama K, Abe S, Kodaira K, Yukawa T, Hozawa S, Morioka J, Inamura H, Ota M, Sagara H, Schwartz LB, Kurosawa M: Arg16Gly ß2-adrenergic receptor gene polymorphism in Japanese patients with aspirin-exacerbated respiratory disease. Int. Arch. Allergy Immunol. 156:405-411,2011.
  • Kashiwase Y, Inamura H, Morioka J, Igarashi Y, Kawai-Kowase K, Kurosawa M: Quantitative analysis of mast cells in benign and malignant colonic lesions: immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Allergol. Immunopathol. 36:271-276,2008.
  • Goto T, Morioka J, Inamura H, Yano M, Kodaira K, Igarashi Y, Abe S, Kurosawa M: Urinary eosinopil-derived neurotoxin concentrations in patients with atopic dermatitis: a useful clinical marker for disease activity. Allergol. Int. 56:433-438,2007.
  • Inamura H, Kashiwase Y, Morioka J, K.Suzuki, Igarashi Y, Kurosawa M: Accumulation of mast cells in the interstitium of eosinophilic colitis. Allergol. Immunopathol. 34:228-230,2006.
  • Inamura H, Igarashi Y, Kashiwase Y, Morioka J, Suzuki K, Kurosawa M: Mast cells in cutaneous allergic vasculitis: a case report. Allergol. Int. 55:343-345,2006.
  • Inamura H, Kashiwase Y, Morioka J, Kurosawa M: Acute pancreatitis possibly caused by allergy to bananas. J. Invest. Allergol. Clin. Immunol. 15:222-224,2005.
  • Morioka J, Tomita M, Yoshizawa Y, Inamura H, Kurosawa M: Concentrations of eosinopil-derived neurotoxin in the blood and urine of patients from patients with allergic diseases. Allergol. Int. 53:359-367,2004.
  • Kashiwase Y, Morioka J, Inamura H, Yoshizawa Y, Usui R, Kurosawa M: Quantitative analysis of mast cells in benign and malignant breast lesions: immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Int. Arch. Allergy Immunol. 134:199-205,2004.
  • Inamura H, Tomita M, Okano A, Kurosawa M: Serial blood and urine levels of EDN and ECP in eosinophilic colitis. Allergy 58:959-960,2003.
  • Inamura H, Kurosawa M, Okano A, Kayaba H, Majima M: Expression of the interleukin-8 receptors CXCR1 and CXCR2 on cord blood-derived cultured human mast cells. Int. Arch. Allergy Immunol. 128:142-150,2002.
  • Sugawara N, Yamashita T, Ote Y, Miura M, Terada N, Kurosawa M: TARC in allergic disease. Allergy 57:180-181,2002.
  • Mochizuki H, Morikawa A, Kurosawa M: Bronchial hyperresponsiveness in a patient with systemic mastocytosis. Respirology 7:285-288,2002.
  • Inamura H, Kurosawa M, Kuwasaki T, Kamada Y, Kayaba H, Chihara J: Expression of adhesion molecules on cord-blood-derived cultured human mast cells and effect of dexamethasone on intercellular adhesion molecule-1 expression on the mast cells treated by phorbol myristate acetate. Allergy 56:672-678,2001.
  • Morioka J, Kurosawa M, Inamura H, Nakagami R, Mizushima Y, Omura Y, Shibata M, Chihara J: Increased EDN/EPX in ongoing asthma. Allergy 55:1203-1204,2000.
  • Amano H, Kurosawa M, Ishikawa O, Chihara J, Miyachi Y: Cultured human mast cells derived from umbilical cord blood cells in the presence of stem cell factor and interleukin-6 can not be a model of human skin mast cells: fluorescence microscopic analysis of intracellular calcium ion mobilization. J. Dermatol. Sci. 24:146-152,2000.
  • Amano H, Kurosawa M, Ishikawa O, Chihara J, Miyachi Y: Mast cells in the cutaneous lesions of sarcoidosis: their subtypes and the relationship to systemic manifestations. J. Dermatol. Sci. 24:60-66,2000.
  • Matsushima Y, Ishikawa O, Kurosawa M, Miyachi Y: Stem cell factor and IL-6 do not promote complete maturation of human cultured mast cells from umbilical cord blood cells: an ultrastructural study. J. Dermatol. Sci. 24:4-13,2000.
  • Kanbe N, Kurosawa M, Miyachi Y, Kanbe M, Saitoh H, Matsuda H: Nerve growth factor prevents apoptosis of cord blood-derived human cultured mast cells synergistically with stem cell factor. Clin. Exp. Allergy 30:1113-1120,2000.
  • Morioka J, Kurosawa M, Inamura H, Nakagami R, Mizushima Y, Chihara J, Yokoseki T, Kitamura S, Omura Y, Shibata M: Development of a novel enzyme-linked immunosorbent assay for blood and urinary eosinophil-derived neurotoxin: a preliminary study in patients with bronchial asthmatic. Int. Arch. Allergy Immunol. 122:49-57,2000.
  • Kanbe N, Kurosawa M, Nagata H, Yamashita T, Kurimoto F, Miyachi Y: Production of fibrogenic cytokines by cord blood-derived cultured human mast cells. J. Allergy Clin. Immunol. 106:S85-90,2000.
  • Abe M, Kurosawa M, Ishikawa O, Miyachi Y: Effect of mast cell-derived mediators and mast cell-related neural proteases on human dermal fibroblast proliferation and type I collagen production. J. Allergy Clin. Immunol. 106:S78-84,2000.
  • Abe M, Kurosawa M, Igarashi Y, Ishikawa O, Miyachi Y: Influence of IgE-mediated activation of cultured human mast cells on proliferation and type I collagen production by human dermal fibroblasts. J. Allergy Clin. Immunol. 106:S72-77,2000.
  • Kurosawa M, Nakagami R, Morioka J, Inamura H, Mizushima Y, Sugawara N,Yamashita T, Yokoseki T, Kitamura S, Omura Y, Shibata M, Chihara J: Interleukins in Churg-Strauss syndrome. Allergy 55:785-787,2000.
  • Kurosawa M, Inamura H, Amano H, Kanbe N, Nagata H, Nagai H, Furukawa S,Miyachi Y: Nerve growth factor release with mast-cell-derived mediators in a patient with systemic mastocytosis after middle-wave ultraviolet irradation. Allergy 54:994-998,1999.
  • Kurosawa M, Amano H, Kanbe N, Igarashi Y, Nagata H, Yamashita T, Kurimoto F,Miyachi Y: Response to cyclosporin and low-dose methylprednisolone in aggressive systemic mastocytosis. J. Allergy Clin. Immunol. 103:S412-420,1999.
  • Kanbe N, Tanaka A, Kanbe M, Itakura A, Kurosawa M, Matsuda H: Human mast cells produce matrix metalloproteinase 9. Eur. J. Immunol. 29:2645-2649,1999.
  • Kanbe N, Kurosawa M, Nagata H, Saitoh H, Miyachi Y: Cord blood-derived human cultured mast cells produce transforming growth factor ß1. Clin. Exp. Allergy 29:105-113,1999.
  • Kanbe N, Kurosawa M, Yamashita T, Kurimoto F, Yanagihara Y, Miyachi Y: Cord-blood-derived human cultured mast cells produce interleukin 13 in the presence of stem cell factor. Int. Arch. Allergy Immunol. 119:138-142,1999.
  • Kurosawa M, Inamura H, Kanbe N, Igarashi Y, Tomita T, Takeda J, Miyachi Y: Phase-contrast microscopic studies using cinematographic techniques and scanning electron microscopy on IgE-mediated degranulation of cultured human mast cells. Clin. Exp. Allergy 28:1007-1012,1998.
  • Abe M, Kurosawa M, Ishikawa O, Miyachi Y, Kido H: Mast cell tryptase stimulates both human dermal fibroblast proliferation and type I collagen production. Clin. Exp. Allergy 28:1509-1517,1998.
  • Inoue M, Kanbe N, Kurosawa M, Kido H: Cloning and tissue distribution of a novel serine protease esp-1 from human eosinophils. Biochem. Biophys. Res. Commun. 252:307-312,1998.
  • Kanbe N, Kurosawa M, Miyachi Y, Kanbe M, Kempuraj D, Tachimoto H, Saito H: Carnoy’s fixative reduces the number of chymase-positive cells in immunocytochemical staining of cord blood-derived human cultured mast cells. Allergy 53:981-985,1998.
  • Hiromura K, Kurosawa M, Yano S, Naruse T: Tubulointerstitial mast cell infiltration in glomerulonephritis. Am. J. Kidney Dis. 32:593-599,1998.
  • Akimoto S, Ishikawa O, Igarashi Y, Kurosawa M, Miyachi Y: Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation. Br. J. Dermatol. 138:399-406,1998.
  • Amano H, Kurosawa M, Miyachi Y: Inhibition of substance P-induced histamine release from rat peritoneal mast cells by 8-methoxypsoralen plus long-wave ultraviolet light irradiation: decreased intracellular calcium as a possible mechanism. Int. Arch. Allergy Immunol. 115:55-60,1998.
  • Amano H, Kurosawa M, Miyachi Y: Inhibition of substance P-induced histamine release from rat peritoneal mast cells by low doses of protoporphyrin plus long-wave ultraviolet light irradiation: decreased intracellular calcium as a possible mechanism. Clin. Exp. Allergy 28:765-771,1998.
  • Kanbe N, Kurosawa M, Igarashi N, Tamura A, Yamashita T, Kurimoto F, Miyachi Y: Idiopathic hypereosinophilic syndrome with elevated plasma interleukin-10 and soluble interleukin-2 receptor. Br. J. Dermatol. 139:916-918,1998.
  • Kanbe N, Kurosawa M, Akimoto S, Sugiyama D, Tamura J, Hirao Y, Miyachi Y: Systemic plasmacytosis with marked deposition of interleukin (IL)-6 and elevated expression of IL-6 mRNA in the skin lesions. Br. J. Dermatol. 138:721-723,1998.
  • Kurosawa M, Shimizu Y, Igarashi Y, Amano H, Kanbe N, Matsushima Y, Ishikawa O, Miyachi Y: 65-Kilodalton protein phosphorylation in human peripheral blood eosinophils. Int.Arch.Allergy Immunol. 114(suppl 1):18-23,1997.
  • Kurosawa M, Amano H, Kanbe N, Akimoto S, Takeuchi Y, Yamashita T, Hashimoto T, Kurimoto F, Miyachi Y: Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis. J. Allergy Clin. Immunol. 100:S25-32,1997.
  • Amano H, Kurosawa M, Miyachi Y: Inhibition of substance P-induced histamine release from rat peritoneal mast cells by ultraviolet light B irradition: decreased intracellular calcium as a partial mechanism. Clin. Exp. Allergy 27:966-971,1997.
  • Amano H, Kurosawa M, Miyachi Y: Possible mechanisms of the concentration-dependent action of substance P to induce histamine release from rat peritoneal mast cells and the effect of extracellular calcium on mast-cell activation. Allergy 52:215-219,1997.
  • Amano H, Akimoto S, Kurosawa M, Ohnishi K, Ishikawa O, Miyachi Y: Confluent and reticulated papillomatosis successfully treated with minocycline. Eur. J. Dermatol. 7:593-595,1997.
  • Kurosawa M, Tsukagoshi H, Igarashi Y, Miyachi Y: CV6209 inhibits airway wall thickening and airway hyperresponsiveness to histamine induced by intravenous administraton of platelet activating factor in guinea pigs. J. Lipid Mediat. Cell Signal. 13:139-149,1996.
  • Kurosawa M, Sunaga Y, Tanaka T: Antipyretic effect of Lumbricus spencer in acetylsalicylic acid-induced asthma: a pilot study. Arzneim. Forsch./Drug Res. 46:172-174,1996.
  • Igarashi Y, Kurosawa M, Ishikawa O, Miyachi Y, Saito H, Ebisawa M, Iikura Y, Yanagida M, Uzumaki H, Nakahata T: Characteristics of histamine release from cultured human mast cells. Clin. Exp. Allergy 26:597-602,1996.
  • Ishikawa O, Tamura A, Ryuzaki K, Kurosawa M, Miyachi Y: Membranocystic changes in the panniculitis of dermatomyositis. Br. J. Dermatol. 134:773-776,1996.
  • Kurosawa M, Yamashita T, Kurimoto F: Increased levels of blood platelet-activating factor in bronchial asthmatic patients with active symptoms. Allergy 49:60-63,1994.
  • Kurosawa M, Inamura H, Shimizu Y: Incorporation of radioactive phosphate from adenosine triphosphate into phosphatidylinositol-4-phosphate in human peripheral blood hypodense eosinophils is less than in the normodense eosinophils. Int. Arch. Allergy Immunol. 103:303-306,1994.
  • Kurosawa M, Yodonawa S, Tsukagoshi H, Miyachi Y: Inhibition by a novel peptide leukotriene receptor antagonist ONO-1078 of airway wall thickening and airway hyperresponsiveness to histamine induced by leukotriene C4 or leukotriene D4 in guinea-pigs. Clin. Exp. Allergy 24:960-968,1994.
  • Kurosawa M, Yodonawa S, Inamura H, Tsukagoshi H: Inhibition by thromboxane antagonists of airway hyperresponsiveness to histamine induced by 13,14-dihydro-15-keto-PGF2α in guinea-pigs. Clin. Exp. Allergy 24:669-675,1994.
  • Kurosawa M, Kobayashi H, Nakano M: Cu-Zu superoxide dismutase activities in platelets from stable bronchial asthmatic patients. Int. Arch. Allergy Immunol. 101:61-65,1993.
  • Kurosawa M, Yodonawa S, Tsukagoshi H: Inhibition of 9α, 11ß-prostaglandin F2 -induced bronchial hyperresponsiveness by thromboxane A2 receptor antagonists in guinea pigs. Eur. J. Pharmacol. 238:335-341,1993.
  • Kurosawa M, Ishizuka T: Inhibitory effects of vasoactive intestinal peptide on superoxide anion formation by N-formyl-methionyl-leucyl-phenylalanine-activated inflammatory cells in vitro. Int. Arch. Allergy Immunol. 100:28-34,1993.
  • Kurosawa M, Yodonawa S, Tsukagoshi H: Inhibition of bronchial hyperresponsiveness to histamine induced by intravenous administration of leukotriene C4 by novel thromboxane A2 receptor antagonists ONO-NT-126 and ONO-8809 in guinea-pigs. Clin. Exp. Allergy 23:843-850,1993.
  • Kurosawa M, Shimizu Y: Granulocyte/macrophage colony-stimulating factor-induced protein phosphorylation in human peripheral blood eosinophils. Immunol. Allergy Prac. 15:280-286,1993.
  • Kurosawa M, Ishizuka T, Shimizu Y: Formation of phosphatidylinositol-4-phosphate in human peripheral blood eosinophils. Clin. Exp. Allergy 23:770-776,1993.
  • Kurosawa M, Tsukagoshi H: Inhibitory effecct of thromboxane A2 synthetase inhibitor OKY-046 on bronchial hyperresponsiveness to histamine, but not on airway wall thickening, induced by intravenous administration of leukotriene C4 in guinea-pigs. Pulm. Pharmacol. 6:247-253,1993.
  • Kurosawa M, Shimizu Y, Tsukagoshi H: Human peripheral blood hypodense eosinophil proteins are more labeled with 32P than the normodense eosinophil proteins. Int. Arch. Allergy Immunol. 97:283-286,1992.
  • Kurosawa M, Hisada T, Ishizuka T: Effect of phospholipase A2 inhibitor ONO-RS-082 on substance P-induced histamine release from rat peritoneal mast cells. Int. Arch. Allergy Immunol. 97:226-228,1992.
  • Kurosawa M, Shimizu Y, Tsukagoshi H, Ueki M: Elevated levels of peripheral-blood, naturally occurring aliphatic polyamines in bronchial asthmatic patients with active symptoms. Allergy 47:638-643,1992.
  • Iwai H, Kurosawa M, Matsui H, Wada O: Inhibitory effects of organotin compounds on histamine release from rat serosal mast cells. Ind. Health 30:77-84,1992.
  • Kurosawa M, Onozato Y, Shimoda T, Matsuzaki T, Okamura S: A case of myasthenia gravis associated with Bartter’s syndrome: is it an autoimmune disease? Immunol. Allergy Prac. 14:411-416,1992.
  • Kurosawa M, Ishizuka T, Kobayashi S, Nakano M: Effects of antiallergic drugs on superoxide anion generation from activated human alveolar macrophages measured by chemiluminescence method. Arzneim. Forsch./Drug Res. 41:47-51,1991.
  • Kurosawa M, Ishizuka T, Kobayashi S, Nakano M, Yodoi J: Effects of azelastine on superoxide anion generation from gamma interferon treated human monoblast cell line U937 measured by chemiluminescence method. Arzneim. Forsch./Drug Res. 41:43-47,1991.
  • Kurosawa M, Kobayashi S: Effect of lobenzarit disodium (CCA) on allergic asthmatic patients. Int. J. Immunotherapy 7:43-51,1991.
  • Kurosawa M, Uno D, Kobayashi S: Naturally occurring aliphatic polyamines-induced histamine release from rat peritoneal mast cells. Allergy 46:349-354,1991.
  • Kurosawa M, Kobayashi H, Kobayashi S, Nakano M: Failure of inhibitory effects by platelets on superoxide anion generation from stimulated neutrophils in a severe bronchial asthmatic. Allergy 46:173-179,1991.
  • Kurosawa M, Hanawa K, Yodonawa S, Kobayashi S, Nakano M: Superoxide anion (O2-) formation from activated peritoneal mast cells in vitro measured by MCLA-dependent luminescence. Immunol. Allergy Prac. 13:235-241,1991.
  • Kurosawa M, Okayama Y, Kobayashi S, Obata K: Rat mast cell granules reacting with a mouse monoclonal antibody M6764 which recognizes the same epitope of mouse monoclonal antibody HNK-1. Int. Arch. Allergy Appl. Immunol. 92:349-355,1990.
  • Kurosawa M, Hanawa K, Kobayashi S, Nakano M: Inhibitory effects of azelastine on superoxide anion generation from activated inflammatory cells measured by a simple chemiluminescence method. Arzneim. Forsch./Drug Res. 40:767-770,1990.
  • Kurosawa M, Igarashi Y, Kobayashi H, Kobayashi S, Abe S: Procedures for plasma prostaglandins assay from bronchial asthmatic patients using 9-anthryldiazomethane-HPLC method. Ann. Allergy 64:464-470,1990.
  • Kurosawa M, Uno D, Hanawa K, Kobayashi S: Polyamines stimulate the phosphorylation of phosphatidylinositol in rat mast cell granules. Allergy 45:262-267,1990.
  • Kurosawa M, Igarashi Y, Kobayashi S, Nakano M, Nishimura K: Measurement by MCLA-dependent luminescence method of superoxide formation by N-formylmethionyl-leucyl-phenylalanine-activated inflammatory cells in vitro. J. Clin. Biochem. Nutr. 8:217-225,1990.
  • Kurosawa M, Kobayashi H, Kobayashi S: Plasma prostaglandin levels from bronchial asthmatic patients assayed by 9-anthryldiazomethane-HPLC method. J. Asthma 27:349-358,1990.
  • Kurosawa M: Inhibitory effects of azelastine on protein kinase C and diphosphoinositide kinase in rat mast cells. Arzneim. Forsch./Drug Res. 40:162-165,1990.
  • Kurosawa M, Kobayashi S, Yanagihara Y, Shida T: Antigen-induced histamine release from peripheral leukocytes of “Konnyaku asthmatic patients”. Ann. Allergy 64:319-321,1990.
  • Kurosawa M, Kobayashi S, Yanagihara Y, Shida T: A case of occupational allergic bronchopulmonary aspergillosis unique in Japan. Brit. J. Clin. Prac. 44:482-489,1990.
  • Kurosawa M, Kobayashi S: Investigation of the effect of ketotifen on alcohol-induced asthma: a case study. J. Int. Med. Res. 18:435-439,1990.
  • Kurosawa M, Parker CW: Changes in polyphosphoinoside metabolism during mediator release from stimulated rat mast cells. Biochem. Pharmacol. 38:431-437,1989.
  • Kurosawa M, Okayama Y, Kobayashi S: Inhibitory effect of adenine nucleotides and anti-allergic drugs on phosphatidylinositol kinase in rat mast cell granules. Allergy 44:576-581,1989.
  • Kurosawa M, Okayama Y, Kobayashi S: A diphosphoinositide kinase in rat mast cell granules. J. Allergy Clin. Immnuol. 84:118-128,1989.
  • Kurosawa M, Kobayashi S: Change in protein kinase C activity during histamine release from activated rat mast cells. Allergy 44:226-232,1989.
  • Kurosawa M, Okayama Y, Kobayashi S: Effect of staurosporine on histamine release from rat serosal mast cells. Ann. Allergy 63:231-234,1989.
  • Kurosawa M, Okayama Y, Kobayashi S: Phorbol myristate acetate stimulates formation of diphosphoinositide in rat mast cell granules. Int. Arch. Allergy Appl. Immunol. 90:373-377,1989.
  • Kurosawa M, Mori H, Nagai H, Koda A: Change in the activity of the cyclic AMP-dependent protein kinase in antigen-stimulated sensitized mast cells and effect of drugs inhibiting allergic mediator release. Jpn. J. Pharmacol. 43:454-457,1987.
  • Kurosawa M, Parker CW: Protein phosphorylation in rat mast cell granules. Cyclic AMP dependent phosphorylation of a 44K protein associated with broken granules. Biochem. Pharmacol. 36:131-140,1987.
  • Kurosawa M: Effect of platelet activating factor on histamine release from rat mast cells. Agents Actions 21(Suppl.):77-85,1987.
  • Kurosawa M, Parker CW: A phosphatidylinositol kinase in rat mast cell granules. J. Immunol. 136:616-622,1986.
  • Kurosawa M, Parker CW: Characterization of calcium-activated, phospholipid-dependent protein kinase from rat serosal mast cells and RBL-1 cells. Cell. Immunol. 103:381-393,1986.
  • Kurosawa M, Nemoto T, Kobayashi S: Insulin release by trimetoquinol in normal and asthmatic subjects. Ann. Allergy 44:317-322,1980.
  • Kurosawa M, Nemoto T, Aoki H, Ike A, Sunaga Y, Kobayashi S: Prostaglandin-induced eosinopenia in splenectomized rats. J. Allergy Clin.Immunol. 62:33-36,1978.